A six-monthly injection to reduce the risk of HIV transmission is being offered to sexually active women in parts of England ...

Lenacapavir, a once-a-year injection, can treat HIV, prevent transmission and stop new infections — all with a single shot.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Funds have also been suspended for AIDS Clinical Trial Group, a nearly 40-year-old system that has been responsible for key ...

The Trump administration's cuts to HIV prevention will lead to new infections, medical costs and death, experts warn.

A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

A trial viewed as the best hope of finding an effective HIV vaccine this decade has ended in failure in another major setback for the field. The PrEPVacc trial in East and Sothern Africa is ...

Much of the federal government's efforts to buoy lagging childhood vaccination rates have been run through the Office of ...

Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...

Pre-exposure prophylaxis, or PrEP, is part of the daily routine for a growing number of Canadians at risk of exposure to HIV through sex or injection drugs. While most people take it in pill ...

“Many researchers working on critical HIV projects have had to be laid off.” One of the projects that has come to a halt was work on a promising vaccine to prevent HIV. The BRILLIANT ...

Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...